AbCellera to Present at Upcoming Investor Conferences in March and April 2026
Thursday, February 12, 2026 1 min read
Key Takeaway: AbCellera has announced its participation in upcoming investor conferences scheduled for March and April 2026. The company will provide live audio webcasts of its presentations, which will also be available for replay afterward. AbCellera specializes in developing antibody-based therapies across various therapeutic areas.
Market Sentiment Analysis
POSITIVE FACTORS
AbCellera is actively engaging with investors.
The company is focused on developing innovative antibody-based medicines.
Presentations at investor conferences can enhance visibility and attract potential partnerships.
Full Press Release Details
VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera(Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:
A live audio webcast of each presentation may be accessed through a link that will be posted onAbCellera’s Investor Relations websitecloser to date. A replay will be available through the same link following the presentation.
About AbCellera Biologics Inc.
AbCellera(Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visitwww.abcellera.com.